HsN3 proteasomal subunit as a target for human immunodeficiency virus type Nef protein

Virology

Volumn 237, Issue 1, 1997, Pages 33-45

  Rossi, F ^a   Evstafieva, A ^a   Pedrali Noy, G ^a   Gallina, A ^a   Milanesi, G ^a  

^a CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; NEF PROTEIN; PROTEASOME;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; PRIORITY JOURNAL; VIRUS PATHOGENESIS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; SIMIAE;

EID: 0030662968     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8752     Document Type: Article

References (61)

1. Aiken C., Konner J., Landau N. R., Lenburg M. E., Trono D. Nef induces CD4 endocytosis: Requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell. 76:1994;853-864.
2. Aiken C., Trono D. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J. Virol. 69:1995;5048-5056.
3. Aiken C., Krause L., Chen Y., Trono D. Mutational analysis of HIV-1 Nef: Identification of two mutants that are temperature-sensitive for CD4 downregulation. Virology. 217:1996;293-300.
4. F. M. Ausbel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, K. ed.s, Struhl, 1991, Current protocols in molecular biology, John Wiley & Sons, New York.
5. Baba T. W., Jeong Y. S., Pennick D., Bronson R., Greene M. F., Ruprecht R. M. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science. 267:1995;1820-1825.
6. Baur A. S., Sawai E. T., Dazin P., Fantl W. J., Cheng-Mayer C., Peterlin B. M. HIV-1 nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity. 1:1994;373-384.
7. Benichou S., Bomsel M., Bodeus M., Durand H., Douté M., Letourneur F., Camonis J., Benarous R. Physical interaction of the HIV-1 Nef protein with β-COP, a component of non-clathrin-coated vesicles essential for membrane traffic. J. Biol. Chem. 269:1994;30073-30076.
8. Bukovsky A. A., Dorfaman T., Weiman A., Göttlinger H. G. Nef association with human immunodeficiency virus type 1 virions and cleavage by the viral protease. J. Virol. 71:1997;1013-1018.
9. Chen P., Hochstrasser M. Autocatalytic subunit processing couples active site formation in the 20S proteasome to completion of assembly. Cell. 86:1996;961-972.
10. Chowers M. Y., Pandori M. W., Spina C. A., Richman D. D., Guatelli J. C. The growth advantage conferred by HIV-1nef. Virology. 212:1995;451-457.
11. Collette Y., Dutartre H., Benziane A., Ramos-Morales F., Benarous R., Harris M., Olive D. Physical and functional interaction of Nef with Lck. HIV-1 Nef-induced T-cell signaling defects. J. Biol. Chem. 271:1996;6333-6341.
12. Coux O., Tanaka K., Goldberg A. L. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65:1996;801-847.
13. Cullen B. R. The role of Nef in the replication cycle of the human and simian immunodeficiency virus. Virology. 205:1994;1-6.
14. Deacon N. J., Tsykin A., Solomon A., Smith K., Ludford-Menting M., Hooker D. J., McPhee D. A., Greenway A. L., Ellett A., Chatfield C., Lawson V. A., Crowe S., Maerz A., Sonza S., Learmont J., Sullivan J. S., Cunningham A., Dwyer D., Dowton D., Mills J. Genomic structure of an attenuated quasi species of HIV-1 from blood transfusion donor and recipients. Science. 270:1995;988-991.
15. Fields S., Song O. A novel genetic system to detect protein-protein interactions. Nature. 340:1989;245-246.
16. Fischer M., Runkel L., Schaller H. HBx protein of hepatitis B virus interacts with the C-terminal portion of a novel human proteasome alpha-subunit. Virus Genes. 10:1995;99-102.
17. Garcia J. V., Miller D. Serine phosphorylation-independent downregulation of cell-surface CD4 bynef. Nature. 350:1991;508-511.
18. Goldsmith M. A., Warmerdam M. T., Atchison R. E., Miller M. D., Greene P. C. Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 Nef. J. Virol. 69:1995;4112-4121.
19. Greenway A., Azad A., Mills J., McPhee D. Human immunodeficiency virus type 1 Nef binds directly to Lck and mitogen-activated protein kinase, inhibiting kinase activity. J. Virol. 70:1996;6701-6708.
20. Groll M., Ditzel L., Lowe J., Stock D., Bochtler M., Bartunik H. D., Huber R. Structure of 20S proteasome from yeast at 2.4 A resolution. Nature. 386:1997;463-471.
21. Grzesiek S., Bax A., Clore G. M., Gronenborn A. M., Hu J., Kaufman J., Palmer I., Stahl S. J., Wingfield P. T. The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase. Nat. Struct. Biol. 3:1996;340-344.
22. Grzesiek S., Stahl S. J., Wingfield P. T., Bax A. The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef. Mapping of the Nef binding surface by NMR. Biochemistry. 35:1996;10256-10261.
23. Harris M. From negative factor to a critical role in virus pathogenesis: the changing fortunes of Nef. J. Gen. Virol. 77:1996;2379-2392.
24. Harris M. P. G., Neil J. C. Myristylation-dependent binding of HIV-1 Nef to CD4. J. Mol. Biol. 241:1994;136-142.
25. Hochstrasser M. Protein degradation or regulation: Ub the judge. Cell. 84:1996;813-815.
26. Huang Y., Baker R. T., Fischer-Vize J. A. Control of cell fate by a deubiquitinating enzyme encoded by thefat facets. Science. 270:1995;1828-1831.
27. Huang J., Kwong J., Sun E. C., Liang T. J. Proteasome complex as a potential cellular target of hepatitis B virus X protein. J. Virol. 70:1996;5582-5591.
28. Jamieson B. D., Aldrovandi G. M., Planelles V., Jowett J. B., Gao L., Bloch L. M., Chen I. S., Zack J. A. Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity. J. Virol. 68:1994;3478-3485.
29. Jones M. H., Furlong R. A., Burkin H., Chalmers J., Brown G. M., Khwaja O., Affara N. A. TheDrosophila. Hum. Mol. Genet. 5:1996;1695-1701.
30. Kaminchik J., Bashan N., Itach A., Sarver N., Gorecki M., Panet A. Genetic characterization of human immunodeficiency virus type 1nef. J. Virol. 65:1991;583-588.
31. Kestler H. W. III, Ringler D. J., Mori K., Panicali D. L., Sehgal P. K., Daniel M. D., Desrosiers R. C. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell. 65:1991;651-662.
32. Kopp F., Kristensen P., Hendil K. B., Johnsen A., Sobek A., Dahlmann B. The human proteasome subunit HsN3 is located in the inner rings of the complex dimer. J. Mol. Biol. 248:1995;264-272.
33. Lee C., Saksela K., Mirza U. A., Chait B. T., Kuriyan J. Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain. Cell. 85:1996;931-942.
34. Lillehoj E. P., Alexander S. S. Jr. Virion-associated transregulatory protein of human T-cell leukemia virus type 1. AIDS Res. Hum. Retroviruses. 8:1992;237-244.
35. Lu X., Wu X., Plemenitas A., Yu H., Sawai E. T., Abo A., Peterlin B. M. CDC42 and Rac1 are implicated in the activation of the Nef-associated kinase and replication of HIV-1. Curr. Biol. 6:1996;1677-1684.
36. Mayer B. J., Eck M. J. Minding your p's and q's. Curr. Biol. 5:1995;364-367.
37. Miller M. D., Warmerdam M. T., Page K. A., Feinberg M. B., Greene W. C. Expression of the human immunodeficiency virus type 1 (HIV-1)nef. J. Virol. 69:1995;579-584.
38. Niederman T. H., Garcia J. V., Hastings W. R., Luria S., Ratner L. Human immunodeficiency virus type 1 Nef protein inhibits NF-kB induction in human T cells. J. Virol. 66:1992;6213-6219.
39. Niederman T. H., Hastings W. R., Luria S., Bandres J. C., Ratner L. HIV-1 Nef protein inhibits the recruitment of AP-1 DNA-binding activity in human T-cells. Virology. 194:1993;338-344.
40. Nothwang H. G., Tamura T., Tanaka K., Ichihara A. Sequence analyses and inter-species comparisons of the novel human proteasomal subunits, HsN3, HsC7-I and HsC10-II, confine potential proteolytic active-site residues. Bioch. Biophys. Acta. 1219:1994;361-368.
41. Nunn M. F., Marsh J. W. Human immunodeficiency virus type 1 Nef associates with a member of the p21-activated kinase family. J. Virol. 70:1996;6157-6161.
42. Palombella V. J., Rando O. J., Goldberg A. L., Maniatis T. The ubiquitin-proteasome pathway is required for processing the NF-kB1 precursor protein and the activation of NF-kB. Cell. 78:1994;773-785.
43. Pandori M. W., Fitch N. J. S., Craig H. M., Richman D. D., Spina C. A., Guatelli J. C. Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein. J. Virol. 70:1996;4283-4290.
44. Ratner L., Niederman T. M. J. Nef. Curr. Top. Microbiol. Immun. 193:1995;169-208.
45. Rhee S. S., Marsh J. W. HIV-1 Nef activity in murine T cells. J. Immunol. 152:1994;5128-5134.
46. Rossi F., Gallina A., Milanesi G. Nef-CD4 physical interaction sensed with the yeast two-hybrid system. Virology. 217:1996;397-403.
47. Rousset R., Desbois C., Bantignies F., Jalinot P. Effects on NF-kB1/p105 processing of the interaction between the HTLV-1 transactivator Tax and the proteasome. Nature. 381:1996;328-331.
48. Rivett A. J., Savory P. J., Djaballah H. Multicatalytic endopeptidase complex: Proteasome. Methods Enzymol. 244:1994;331-350.
49. +. EMBO J. 14:1995;484-491.
50. Samuel K. P., Hodge D. V., Chen Y. A., Papas T. S. Nef proteins of the human immunodeficiency viruses (HIV-1 and HIV-2) and simian immunodeficiency virus (SIV) are structurally similar to leucine zipper transcriptional activation factors. AIDS Res. Hum. Retroviruses. 7:1991;697-706.
51. Sawai E. T., Khan I. H., Montbriand P. M., Peterlin B. M., Cheng-Mayer C., Luciw P. A. Activation of PAK by HIV and SIV Nef: importance for AIDS in rhesus macaques. Curr. Biol. 6:1996;1519-1527.
52. Schmidtke G., Kraft R., Kostka S., Henklein P., Frömmel C., Löwe J., Huber R., Kloetzel P. M., Schmidt M. Analysis of mammalian 20S proteasome biogenesis: the maturation of β-subunits is an ordered two-step mechanism involving autocatalysis. EMBO J. 15:1996;6887-6898.
53. Schwartz O., Marechal V., Danos O., Heard J. Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. J. Virol. 69:1995;4053-4059.
54. Schwartz O., Marechal V., Le Gall S., Lemonnier F., Heard J. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. Med. 2:1996;338-342.
55. Skowronski J., Parks D., Mariani R. Altered T cell activation and development in transgenic mice expressing the HIV-1nef. EMBO J. 12:1993;703-713.
56. Smith B. L., Krushelnycky B. W., Mochly-Rosen D., Berg P. The HIV Nef protein associates with Protein kinase C theta. J. Biol. Chem. 271:1996;16753-16757.
57. Swingler S., Gallay P., Camaur D., Song J., Abo A., Trono D. The Nef protein of human immunodeficiency virus type 1 enhances serine phosphorylation of the viral matrix. J. Virol. 71:1997;4372-4377.
58. Thomson S., RIvett A. J. Processing of N3, a mammalian proteasome beta-type subunit. Biochem. J. 315:1996;733-738.
59. Trono D. HIV accessory proteins: leading roles for the supporting cast. Cell. 82:1995;189-192.
60. Welker R., Kottler H., Kalbitzer H. R., Kräusslich H. Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase. Virology. 219:1996;228-236.
61. Wu J. Y., Zhou Z. Y., Judd A., Cartwright C. A., Robinson W. S. The hepatitis B virus-encoded transcriptional trans-activator hbx appears to be a novel protein serine/threonine kinase. Cell. 63:1990;687-695.